WORLDQUANT MILLENNIUM ADVISORS LLC
Position in VKTX — Viking Therapeutics, Inc.
CIK 1745981
NEW YORK, NY
Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,574,642
New position
Shares Held
91,634
first reported quarter
Ownership
0.079%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#86
of 435 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026WORLDQUANT MILLENNIUM ADVISORS LLC holds $380,210,326 across 20 Biotechnology names. VKTX ranks #12 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
353,970 | $220,714,453 | |
| 2 | INCY |
Incyte Corp
|
486,810 | $55,184,781 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
62,180 | $18,718,045 | |
| 4 | EXEL |
Exelixis, Inc.
|
322,838 | $17,565,615 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
72,619 | $13,600,086 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
55,396 | $13,348,774 | |
| 7 | INSM |
INSMED Inc
|
69,199 | $7,377,997 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
214,374 | $7,157,947 |
All Filings in VKTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,574,642 | 91,634 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||